Christine Duncan
Pediatric Hematology-Oncology · Boston, MANPI 1376583807
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $76,844 of the $88,837 with a category attached, or 86.5%. 15 manufacturers reported payments, led by Genetix Biotherapeutics Inc at 27.1% of the total. Among pediatric hematology-oncology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $1184.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genetix Biotherapeutics Inc$24K
- Sanofi$13K
- Gamida Cell Inc.$11K
- Omeros Corporation$10K
- AstraZeneca$9K
- Vertex$8K
- plus $15K from 9 others
Across 23 payments — averaging $65,249 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genetix Biotherapeutics Inc$1.5M
- Pfizer$5K
- Merck$421
What the payments were for
- Consulting fees$76,84487%
- Speaking & faculty fees$4,2755%
- Travel & lodging$4,0985%
- Food & beverage$3,6204%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genetix Biotherapeutics Inc | 10 | $24,040 |
| Sanofi | 6 | $12,925 |
| Gamida Cell Inc. | 2 | $10,722 |
| Omeros Corporation | 10 | $9,598 |
| AstraZeneca | 5 | $8,541 |
| Vertex | 11 | $7,991 |
| Partner Therapeutics, Inc. | 2 | $7,975 |
| Jazz Pharmaceuticals Inc. | 19 | $5,953 |
| Terumo BCT, Inc. | 1 | $275 |
| Sobi, Inc | 4 | $181 |
| Mesoblast, Inc. | 1 | $175 |
| Medexus Pharma, Inc. | 1 | $137 |
| Syndax Pharmaceuticals, Inc. | 1 | $135 |
| Novartis | 1 | $118 |
| Iovance Biotherapeutics, Inc. | 1 | $70 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$88,837 in reported general payments places this provider in the 90th percentile of 114 pediatric hematology-oncology providers in Massachusetts.
See all pediatric hematology-oncology providers in Massachusetts →
Other pediatric hematology-oncology in Boston
- Leslie KeanBoston$558K
- Todd GolubBoston$213K
- Rachael GraceBoston$201K
- Stacy CroteauBoston$117K
- Matthew HeeneyBoston$101K
- Susan PerrineBoston$96K
- Eric GrabowskiBoston$56K
- Derek HansonBoston$54K
- Susan ParsonsBoston$47K
- Karen BrideBoston$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.